3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Recruiting
1
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Multiple Myeloma
3
Lymphoma
3
Leukemia
3
Hematologic Neoplasms
3
Triple Negative Breast Neoplasms
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Glioblastoma
2
Fallopian Tube Neoplasms
2
Urinary Bladder Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Malignant Female Reproductive System Neoplasm
1
Localized Head and Neck Carcinoma
1
Leukemia, Myeloid, Acute
1
Hematopoietic and Lymphoid System Neoplasm
1
Gastrointestinal Neoplasms
1
Fatigue
1
Endometrial Neoplasms
1
Depression
1
Colonic Neoplasms
1
Chemotherapy Effect
1
Caregiver Burden
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Anxiety Disorders
1
Interventions
Cyclophosphamide
55
fludarabine
29
Methotrexate
25
blinatumomab
22
Dexamethasone
22
Cytarabine
21
Vincristine
20
venetoclax
18
fludarabine phosphate
15
Specimen Handling
15
Whole-Body Irradiation
13
Stem Cell Transplantation
11
Biopsy
11
Tacrolimus
10
Prednisone
10
Mycophenolic Acid
10
Mercaptopurine
10
Daunorubicin
10
Thiotepa
9
Rituximab
9
Melphalan
9
Immunotherapy, Adoptive
9
Doxorubicin
8
pegaspargase
7
Magnetic Resonance Spectroscopy
7
Inotuzumab Ozogamicin
7
Granulocyte Colony-Stimulating Factor
7
Cyclosporine
7
Calcium Dobesilate
7
ponatinib
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
Palliative Care
×
Clear all
NCT07258043
2025-12-02
EPOCH
Hospital General de Mexico
Recruiting
45 enrolled